Patent ID: 8003105
Filing Date: 2011-08-23
Classification: A61K,A61P,C07D,Y10S

Abstract:
1. A method for treatment of a cancer patient, which comprises administering an effective amount of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazol-3-ium bromide to said patient, combined with i) rituximab, ii) a combination therapy R-ICE consisting of rituximab, ifosfamide, carboplatin and etoposide, or iii) a combination therapy R-DHAP consisting of rituximab, cytarabine and cisplatin as anticancer agents.